Multisystem Inflammatory Syndrome in Children

Multisystem inflammatory syndrome in children (MIS-C), which was first documented in the United Kingdom and later recognized in other countries, is a postinfectious immune response to coronavirus disease 2019 (COVID-19). Its clinical manifestation resembles that of other inflammatory processes. Diff...

Descripción completa

Detalles Bibliográficos
Autor principal: Holstein, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Feature Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258545/
https://www.ncbi.nlm.nih.gov/pubmed/34248441
http://dx.doi.org/10.1016/j.nurpra.2021.05.008
_version_ 1783718517884846080
author Holstein, Barbara
author_facet Holstein, Barbara
author_sort Holstein, Barbara
collection PubMed
description Multisystem inflammatory syndrome in children (MIS-C), which was first documented in the United Kingdom and later recognized in other countries, is a postinfectious immune response to coronavirus disease 2019 (COVID-19). Its clinical manifestation resembles that of other inflammatory processes. Differentiation can be accomplished through epidemiology, a positive temporal relationship to COVID-19, and multiorgan involvement. Health care providers should maintain a high level of suspicion for MIS-C during the COVID-19 pandemic. A consistent picture of this immune response is emerging and diagnostic and treatment approaches are evolving. Advances continue to be made in the knowledge attainment regarding MIS-C clinical presentation and management.
format Online
Article
Text
id pubmed-8258545
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-82585452021-07-06 Multisystem Inflammatory Syndrome in Children Holstein, Barbara J Nurse Pract Feature Article Multisystem inflammatory syndrome in children (MIS-C), which was first documented in the United Kingdom and later recognized in other countries, is a postinfectious immune response to coronavirus disease 2019 (COVID-19). Its clinical manifestation resembles that of other inflammatory processes. Differentiation can be accomplished through epidemiology, a positive temporal relationship to COVID-19, and multiorgan involvement. Health care providers should maintain a high level of suspicion for MIS-C during the COVID-19 pandemic. A consistent picture of this immune response is emerging and diagnostic and treatment approaches are evolving. Advances continue to be made in the knowledge attainment regarding MIS-C clinical presentation and management. Elsevier Inc. 2021-09 2021-07-06 /pmc/articles/PMC8258545/ /pubmed/34248441 http://dx.doi.org/10.1016/j.nurpra.2021.05.008 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Feature Article
Holstein, Barbara
Multisystem Inflammatory Syndrome in Children
title Multisystem Inflammatory Syndrome in Children
title_full Multisystem Inflammatory Syndrome in Children
title_fullStr Multisystem Inflammatory Syndrome in Children
title_full_unstemmed Multisystem Inflammatory Syndrome in Children
title_short Multisystem Inflammatory Syndrome in Children
title_sort multisystem inflammatory syndrome in children
topic Feature Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258545/
https://www.ncbi.nlm.nih.gov/pubmed/34248441
http://dx.doi.org/10.1016/j.nurpra.2021.05.008
work_keys_str_mv AT holsteinbarbara multisysteminflammatorysyndromeinchildren

Ejemplares similares